Jing Bao

2.3k citations
36 papers · 1.4k indexed · 1 hit paper · h-index 14
Topics
Tuberculosis Research and Epidemiology (5 papers)Glioma Diagnosis and Treatment (4 papers)Pharmacological Effects and Toxicity Studies (4 papers)

In The Last Decade

Jing Bao

29 papers receiving 1.4k citations

Hit Papers

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-1920202026202220242020250500750

Peers

Jing Bao
Comparison fields: 5 of 126
  • Infectious Diseases 659
  • Neurology 283
  • Molecular Biology 267
  • Oncology 235
  • Epidemiology 152
Replace Lianghong Yin with:
Lianghong Yin China
Dina Ragab Egypt
Runming Jin China
Amaal Eman Abdulle Netherlands
Ramy Salem Egypt
Yancheng Xu China
Dawei Wang China
Yaohua Fan China
Jing Bao relative to Lianghong Yin China Lianghong Yin's profile →
Citations per field
00.5×1.5×
Lianghong Yin · 1×
Citations per year

Countries citing papers authored by Jing Bao

Since Specialization
Citations

This map shows the geographic impact of Jing Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Bao more than expected).

Fields of papers citing papers by Jing Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Bao. The network helps show where Jing Bao may publish in the future.

Co-authorship network of co-authors of Jing Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Bao. A scholar is included among the top collaborators of Jing Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Bao. Jing Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 0
6 2
7 16
8 9
9 10
10 11
11 15
12 0
13 1
14 56
15 30
16 51
17 75
18
Advantages and challenges conducting clinical trials in china
1
19 9
20 23

About Jing Bao

Jing Bao is a scholar working on Infectious Diseases, Complementary and Manual Therapy and Neurology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Infectious Diseases (659 citations), Neurology (283 citations) and Pharmacology (83 citations). Jing Bao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhancheng Gao, Wentao Ni, Xiuwen Yang, Donghong Yang, Yu Xu, Chang Hou, Yongjiu Xiao, Zhaolong Cao, Jie Liu and Haibin Wang. Their work appears in journals such as Journal of the American College of Cardiology, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026